Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance.
Robert A ScottTimothy J S CrossChristopher G D ClarkeShahid A KhanStephen D RyderJames FranklinAloysious D AravinthanPublished in: Journal of hepatocellular carcinoma (2023)
Most responding NHS hospitals follow 6-monthly HCC surveillance guidance. Data recording is variable, with limited routine data collection regarding compliance, yield, and quality. Surveillance US is mostly performed by non-HPB specialists without standardised reporting. There is an inconsistent approach to poor views with US surveillance. Even in a universal healthcare system such as NHS, which is free at the point of care, delivery of HCC surveillance has not improved over the last decade and remains variable.